Imerys (NK) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Revenue for the first nine months of 2024 reached €2,773 million, with Q3 revenue at €855 million, reflecting solid volume recovery and stable pricing year-over-year, driven by specialty minerals and market share gains.
Adjusted EBITDA for the first nine months was €533 million (+3% year-over-year), with a margin of 19.2% (+140 bps), supported by cost reductions, operating leverage, and joint venture contributions.
Current net income (group share) for nine months at €214 million, up 11.3% year-over-year.
Net income, group share, was -€143 million for the first nine months, impacted by a non-cash translation reserve loss from the disposal of paper market assets.
Full-year 2024 adjusted EBITDA guidance is confirmed at €670–690 million, reflecting confidence in operational resilience.
Financial highlights
Q3 2024 organic revenue growth was 4.1% year-over-year, with volumes up 3.8% and prices up 0.3%.
Year-to-date organic revenue growth was 0.1%, with volumes up 0.9% and prices down 0.8%.
Adjusted EBITDA for Q3 was €148 million; nine-month adjusted EBITDA at €533 million, with a 19.2% margin (up 140–150 bps year-over-year).
Current operating income for nine months at €330 million (11.9% of sales), up 9.8% year-over-year.
Net income, group share, for nine months was -€143 million, mainly due to a non-cash translation reserve loss.
Outlook and guidance
Full-year 2024 adjusted EBITDA guidance maintained at €670–690 million, reflecting confidence in resilience and a diversified portfolio.
Management remains prudent due to macroeconomic and geopolitical uncertainties but expects continued outperformance and volume-driven growth.
Construction and residential markets expected to recover as interest rates fall, providing further growth potential.
Latest events from Imerys
- H1 2026 saw 1.8% revenue and 10% EBITDA growth, margin gains, and strong cash flow.NK
Q2 2026 - Stable results, €0.75 dividend, strategic focus on lithium, cost savings, and strong ESG progress.NK
AGM 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 2025 - Nine-month revenue fell 0.7% to €2,583m; EBITDA guidance and cost actions reaffirmed.NK
Q3 2025 - H1 2024 adjusted EBITDA up 11% to €384m, margin 20%, and net income from continuing ops up 25%.NK
H1 2024 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 2025 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 2025 - Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 2024